A history of ICI therapy is a strong independent predictor for the development of symptomatic pneumonitis among patients receiving enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma. Prior treatment with an immune checkpoint inhibitor... See more
Prior treatment with an immune checkpoint inhibitor (ICI) increased the risk of pneumonitis, particularly grade 2 or worse, in patients with locally advanced or metastatic urothelial carcinoma (LA/mUC) undergoing treatment with enfortumab vedotin plus pem... See more
Prophylactic goshajinkigan reduced the incidence of grade 2 or higher chemotherapy-induced peripheral neuropathy in patients receiving carboplatin plus paclitaxel. A traditional Japanese herbal medicine known as goshajinkigan (GJG) has potential for preve... See more
Muscle weakness, muscle loss, and delirium are just a few of the complications that often arise when a patient remains immobilized in a hospital bed. "And the decline in functional status can really occur as early as day 2 of hospitalization," said Marla ... See more
To ensure patients with cancer receive high-quality care, oncology programs may need to take a close look at strategies for improving the relationship between their team and the palliative care team, according to the results of a study recently published ... See more
